• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新诊断需要血液透析的多发性骨髓瘤患者血液透析独立性高的相关影响因素。

Effect factors related to a high probability of hemodialysis independence in newly diagnosed multiple myeloma patients requiring hemodialysis.

机构信息

Department of Hematology, Tianjin Medical University General Hospital, Tianjin, China.

出版信息

J Clin Lab Anal. 2020 Feb;34(2):e23057. doi: 10.1002/jcla.23057. Epub 2019 Oct 30.

DOI:10.1002/jcla.23057
PMID:31663630
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7031559/
Abstract

BACKGROUND

Renal failure is a severe complication of symptomatic myeloma, related to higher mortality. Recovery from dialysis dependence can lead to enormous survival benefits. We investigated the effect factors for probability of dialysis independence.

METHODS

Retrospective data on 45 newly diagnosed MM (NDMM) patients with serious renal impairment and requiring hemodialysis were analyzed. The statistical methods including logistic regression analysis, Kaplan-Meier survival curves, the log-rank test and the Cox proportional hazards model for survival analysis were used in our study.

RESULTS

Twenty-two of the 45 patients, who were on hemodialysis at diagnosis, became dialysis independence. In the logistic regression analysis, serum level of β2-microglobulin, kidney disease history, involved free light chain, and achieving at least VGPR were significantly associated with reversibility from dialysis dependence. In addition, achieving hemodialysis discontinuation was related to better survival. The multivariate analyses demonstrated that reversibility from dialysis dependence, proteinuria < 3.5 g/24 h, and achieving at least VGPR were significantly associated with OS among NDMM patients requiring hemodialysis.

CONCLUSION

Lower serum level of β2-microglobulin and lower level of free light chain at diagnosis, achieving at least VGPR, and shorter kidney disease history are related to a high probability of dialysis independence in NDMM patients with serious renal failure requiring dialysis.

摘要

背景

肾功能衰竭是症状性骨髓瘤的严重并发症,与更高的死亡率相关。摆脱透析依赖可带来巨大的生存获益。我们研究了影响透析独立性概率的因素。

方法

回顾性分析了 45 例新诊断的严重肾功能损害且需要血液透析的 MM(NDMM)患者的资料。本研究采用了逻辑回归分析、Kaplan-Meier 生存曲线、对数秩检验和 Cox 比例风险模型进行生存分析。

结果

在诊断时接受血液透析的 45 例患者中有 22 例实现了透析独立性。在逻辑回归分析中,血清β2-微球蛋白水平、肾脏病病史、游离轻链受累以及获得至少 VGPR 与从透析依赖中逆转显著相关。此外,停止血液透析与更好的生存相关。多因素分析表明,在需要血液透析的 NDMM 患者中,从透析依赖中逆转、蛋白尿<3.5g/24h 和获得至少 VGPR 与 OS 显著相关。

结论

较低的血清β2-微球蛋白和游离轻链水平、获得至少 VGPR 以及较短的肾脏病病史与需要透析的严重肾功能衰竭的 NDMM 患者实现透析独立性的高概率相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a9b/7031559/f97f9601e0a9/JCLA-34-e23057-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a9b/7031559/5138ce537f26/JCLA-34-e23057-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a9b/7031559/f97f9601e0a9/JCLA-34-e23057-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a9b/7031559/5138ce537f26/JCLA-34-e23057-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a9b/7031559/f97f9601e0a9/JCLA-34-e23057-g002.jpg

相似文献

1
Effect factors related to a high probability of hemodialysis independence in newly diagnosed multiple myeloma patients requiring hemodialysis.新诊断需要血液透析的多发性骨髓瘤患者血液透析独立性高的相关影响因素。
J Clin Lab Anal. 2020 Feb;34(2):e23057. doi: 10.1002/jcla.23057. Epub 2019 Oct 30.
2
Bortezomib-based triplets are associated with a high probability of dialysis independence and rapid renal recovery in newly diagnosed myeloma patients with severe renal failure or those requiring dialysis.硼替佐米为基础的三联方案在新诊断的伴有严重肾功能衰竭或需要透析的骨髓瘤患者中,具有较高的透析独立性和快速肾功能恢复的可能性。
Am J Hematol. 2016 May;91(5):499-502. doi: 10.1002/ajh.24335. Epub 2016 Apr 4.
3
Treatment of acute renal failure secondary to multiple myeloma with chemotherapy and extended high cut-off hemodialysis.采用化疗及延长高通量血液透析治疗多发性骨髓瘤继发的急性肾衰竭。
Clin J Am Soc Nephrol. 2009 Apr;4(4):745-54. doi: 10.2215/CJN.04590908. Epub 2009 Apr 1.
4
Lack of Renal Recovery Predicts Poor Survival in Patients of Multiple Myeloma With Renal Impairment.肾功能恢复不良预示肾功能损害的多发性骨髓瘤患者生存不良。
Clin Lymphoma Myeloma Leuk. 2022 Aug;22(8):626-634. doi: 10.1016/j.clml.2022.04.013. Epub 2022 Apr 20.
5
Hemodialysis: an appropriate therapy in myeloma-induced renal failure.血液透析:骨髓瘤所致肾衰竭的一种合适治疗方法。
Am J Kidney Dis. 1997 Dec;30(6):786-92. doi: 10.1016/s0272-6386(97)90083-4.
6
Outcome of patients with multiple myeloma and renal failure on novel regimens.采用新方案治疗的多发性骨髓瘤合并肾衰竭患者的治疗结果。
Saudi J Kidney Dis Transpl. 2016 Mar;27(2):335-40. doi: 10.4103/1319-2442.178557.
7
Trends in Survival and Renal Recovery in Patients with Multiple Myeloma or Light-Chain Amyloidosis on Chronic Dialysis.接受长期透析的多发性骨髓瘤或轻链淀粉样变性患者的生存及肾脏恢复趋势
Clin J Am Soc Nephrol. 2016 Mar 7;11(3):431-41. doi: 10.2215/CJN.06290615. Epub 2016 Jan 4.
8
Association of Dose and Frequency on the Survival of Patients on Maintenance of Hemodialysis in China: A Kaplan-Meier and Cox-Proportional Hazard Model Analysis.中国维持性血液透析患者生存的剂量和频率相关性:一项 Kaplan-Meier 和 Cox 比例风险模型分析。
Med Sci Monit. 2018 Jul 31;24:5329-5337. doi: 10.12659/MSM.909404.
9
Extracorporeal light chain elimination: high cut-off (HCO) hemodialysis parallel to chemotherapy allows for a high proportion of renal recovery in multiple myeloma patients with dialysis-dependent acute kidney injury.体外轻链清除:高截止(HCO)血液透析与化疗并行,可使透析依赖的急性肾损伤多发性骨髓瘤患者有很大比例的肾功能恢复。
Ann Hematol. 2012 May;91(5):729-735. doi: 10.1007/s00277-011-1383-0. Epub 2011 Dec 15.
10
Patients with multiple myeloma have excellent long-term outcomes after recovery from dialysis-dependent acute kidney injury.多发性骨髓瘤患者在从依赖透析的急性肾损伤中恢复后,具有出色的长期预后。
Eur J Haematol. 2016 Jun;96(6):610-7. doi: 10.1111/ejh.12644. Epub 2015 Sep 16.

引用本文的文献

1
Clinicopathologic predictors of renal response and survival in newly diagnosed multiple myeloma with renal injury: a retrospective study.新诊断的合并肾损伤的多发性骨髓瘤患者肾脏反应和生存的临床病理预测因素:一项回顾性研究
Clin Exp Med. 2025 Feb 4;25(1):48. doi: 10.1007/s10238-025-01571-9.
2
Circulating miRNAs as diagnostic biomarkers for multiple myeloma and monoclonal gammopathy of undetermined significance.循环 miRNA 作为多发性骨髓瘤和意义未明的单克隆丙种球蛋白血症的诊断生物标志物。
J Clin Lab Anal. 2020 Jun;34(6):e23233. doi: 10.1002/jcla.23233. Epub 2020 Feb 10.

本文引用的文献

1
[Multiple Myeloma - Current Status in Diagnostic Testing and Therapy].[多发性骨髓瘤——诊断检测与治疗的现状]
Z Orthop Unfall. 2017 Oct;155(5):575-586. doi: 10.1055/s-0043-110224. Epub 2017 Aug 14.
2
Rediscovering Beta-2 Microglobulin As a Biomarker across the Spectrum of Kidney Diseases.重新发现β2微球蛋白作为全谱肾脏疾病生物标志物的价值
Front Med (Lausanne). 2017 Jun 15;4:73. doi: 10.3389/fmed.2017.00073. eCollection 2017.
3
Outcomes of newly diagnosed myeloma patients requiring dialysis: renal recovery, importance of rapid response and survival benefit.
新诊断的需要透析的骨髓瘤患者的预后:肾脏恢复、快速反应的重要性及生存获益
Blood Cancer J. 2017 Jun 16;7(6):e571. doi: 10.1038/bcj.2017.49.
4
Serum free light chains, not urine specimens, should be used to evaluate response in light-chain multiple myeloma.应使用血清游离轻链而非尿液标本评估轻链型多发性骨髓瘤的反应。
Blood. 2016 Dec 22;128(25):2941-2948. doi: 10.1182/blood-2016-07-726778. Epub 2016 Oct 11.
5
The Prevalence and Management of Multiple Myeloma-Induced Kidney Disease in China.中国多发性骨髓瘤相关性肾病的流行状况和管理。
Kidney Dis (Basel). 2016 Mar;1(4):235-40. doi: 10.1159/000443492. Epub 2016 Jan 21.
6
International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma.国际骨髓瘤工作组多发性骨髓瘤反应和微小残留病评估的共识标准。
Lancet Oncol. 2016 Aug;17(8):e328-e346. doi: 10.1016/S1470-2045(16)30206-6.
7
International Myeloma Working Group Recommendations for the Diagnosis and Management of Myeloma-Related Renal Impairment.国际骨髓瘤工作组关于骨髓瘤相关肾脏损害的诊断和管理建议。
J Clin Oncol. 2016 May 1;34(13):1544-57. doi: 10.1200/JCO.2015.65.0044. Epub 2016 Mar 14.
8
Bortezomib-based triplets are associated with a high probability of dialysis independence and rapid renal recovery in newly diagnosed myeloma patients with severe renal failure or those requiring dialysis.硼替佐米为基础的三联方案在新诊断的伴有严重肾功能衰竭或需要透析的骨髓瘤患者中,具有较高的透析独立性和快速肾功能恢复的可能性。
Am J Hematol. 2016 May;91(5):499-502. doi: 10.1002/ajh.24335. Epub 2016 Apr 4.
9
Multiple Myeloma, Version 2.2016: Clinical Practice Guidelines in Oncology.多发性骨髓瘤,2016年第2版:肿瘤学临床实践指南
J Natl Compr Canc Netw. 2015 Nov;13(11):1398-435. doi: 10.6004/jnccn.2015.0167.
10
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma.国际骨髓瘤工作组更新了多发性骨髓瘤的诊断标准。
Lancet Oncol. 2014 Nov;15(12):e538-48. doi: 10.1016/S1470-2045(14)70442-5. Epub 2014 Oct 26.